基于脂质体的纳米药物用于免疫检查点阻断疗法和结合性癌症疗法
Haoyuan Zhou1, Cui-Yun Yu1, Hua Wei1
1Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical of Science, Hengyang 421001, China.
International journal of pharmaceutics
|January 22, 2024
概括
本综述探讨了脂质体在癌症中用于免疫检查点阻塞 (ICB) 疗法. 脂质体提供了一个有前途的策略,以克服ICB的局限性,并提高免疫治疗的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 免疫检查点 (IC) 的发现彻底改变了癌症免疫疗法.
- 免疫检查点阻塞 (ICB) 疗法显示出希望,但在响应率和副作用方面面临局限性.
- 研究纳米载体,特别是脂质体,以提高ICB的有效性和安全性.
研究的目的:
- 审查当前ICB治疗的挑战和局限性.
- 通过组合疗法探索克服ICB限制的策略.
- 突出脂质体在开发先进的结合性癌症免疫疗法的作用.
主要方法:
- 文献综述侧重于ICB疗法,组合策略和纳米载体应用.
- 对药物输送和癌症治疗中的脂质体现有研究进行分析.
- 关于用于增强免疫治疗的脂质体介导组合疗法信息的综合.
主要成果:
- 虽然ICB疗法具有突破性,但临床反应率和不良反应阻碍了它.
- 使用纳米载体,特别是脂质体的组合疗法,是解决ICB局限性的可行策略.
- 脂质体表现出广泛的药物递送能力和临床应用的有利安全性.
结论:
- 脂质体在结合性癌症治疗中具有重要的媒介潜力,以提高ICB的疗效.
- 本综述为设计基于脂质体的免疫疗法提供了指导,改善了治疗结果.
- 对脂质体应用的进一步研究可以在癌症免疫治疗中建立基础科学和临床翻译的桥梁.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


